South African government threatens to ban nevirapine. Move would take away option for treating vertical HIV transmission.
Baleta
Adele
A
D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000592:standards; D004196:Disease Outbreaks / Q000517:prevention & control; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission*; D006291:Health Policy / Q000331:legislation & jurisprudence; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019829:Nevirapine / Q000627:therapeutic use*; D028701:Patient Rights / Q000639:trends; D011247:Pregnancy; D013019:South Africa / Q000453:epidemiology; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D019829:Nevirapine